Research Papers

25 of 153 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Immune checkpoint inhibitors: friend or foe for osteoporosis.
Tang J.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Screening for MAFLD: who, when and how?
Pal SC; Méndez-Sánchez N.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the D…
Boutsen L; Costenoble E; Pollé O; Erdem K; Bugli C; Lysy PA.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activitie…
Ababneh A; Finlayson K; Edwards H; van Netten JJ; Lazzarini PA.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Emerging pharmacological treatment options for MAFLD.
Rojas Á; Lara-Romero C; Muñoz-Hernández R; Gato S; Ampuero J; Romero-Gómez M.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Potential immunological effects of gender-affirming hormone therapy in transgender people - an unexplored area of resea…
White AA; Lin A; Bickendorf X; Cavve BS; Moore JK; Siafarikas A; Strickland DH; Leffler J.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a met…
Ren B; Chen M.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Non-invasive assessment of metabolic dysfunction-associated fatty liver disease.
Chandra Kumar CV; Skantha R; Chan WK.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeast…
Liu Y; Li Y; Shen H; Li Y; Xu Y; Zhou M; Xia X; Shi B.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized …
Ma Q; Ye J; Shao C; Lin Y; Wu T; Zhong B.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Ankle brachial indices and anaerobes: is peripheral arterial disease associated with anaerobic bacteria in diabetic foo…
Cheong JZA; Irvine JM; Roesemann S; Nora A; Morgan CE; Daniele C; Kalan LR; Brennan MB.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters.
Sandeep NV; Joseph A; Cherian KE; Kapoor N; Paul TV.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Timing of osteoporosis therapies following fracture: the current status.
Palui R; Durgia H; Sahoo J; Naik D; Kamalanathan S.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Relationship between total testosterone, sex hormone-binding globulin levels and the severity of non-alcoholic fatty li…
Mo MQ; Huang ZC; Yang ZH; Liao YH; Xia N; Pan L.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Relationship between sleep pattern and bone mineral density in patients with osteoporotic fracture.
Zeng H; Li L; Zhang B; Xu X; Li G; Chen M.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabetes mellitus.
Li W; Zhao J; Zhu LL; Peng YF.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Bone health in transgender people: a narrative review.
Giacomelli G; Meriggiola MC.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Calcitonin: current concepts and differential diagnosis.
Kiriakopoulos A; Giannakis P; Menenakos E.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomye…
Yin X; Zhu W; Liu C; Yao H; You J; Chen Y; Ying X; Li L.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study.
Jungnickel T; von Jan U; Engeli S; Albrecht UV.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease …
Li Y; Huang Y; He X; Han C; Wu W; Shen H; Xu Y; Liu Y; Zhu Z.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2…
Al-Badri M; Kilroy CL; Shahar JI; Tomah S; Gardner H; Sin M; Votta J; Phillips-Stoll A; Price A; Beaton J; Davis C; Rizzotto JA; Dhaver S; Hamdy O.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?
Ujjawal A; Schreiber B; Verma A.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clin…
Bomberg EM; Palzer EF; Rudser KD; Kelly AS; Bramante CT; Seligman HK; Noni F; Fox CK.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes.
Abdalrada AS; Abawajy J; Al-Quraishi T; Islam SMS.
Ther Adv Endocrinol Metab (Unknown)
Published: 2022
3/6 Transparent
Funding Declared